Namenda
Drug - Namenda
The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Memantine Hydrochloride
Multiple ingredients are in alphabetical order.
Strength -
2MG/ML
The potency of the active ingredient(s), Memantine Hydrochloride. May repeat for multiple part products.
Applicant -
FOREST LABS
The firm name holding legal responsibility for Namenda. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
021627
The FDA assigned number to Namenda. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Namenda. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Apr 18, 2005
The date Namenda was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Namenda. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Namenda is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Forest Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Namenda.
Namenda
|
